Liver disease podcast series

Published Last updated See all updates
Topics: Liver disorders

Pharmacy colleagues and expert clinical speakers talk about liver disease and drugs in liver impairment.

About the podcast series

The incidence of liver disease in the UK is increasing and it is important that healthcare professionals are equipped to manage patients with liver disease. Nine out of ten cases of liver disease can be prevented and healthcare professionals are well placed to make interventions and provide advice to reduce these risks.

This podcast series has been developed in collaboration with the British Hepatology Pharmacy Group.

Liver disease

Kieran Reynolds talks to Sital Shah, Consultant Hepatology Pharmacist, in our introductory podcast about liver disease. Discussion includes the functions of the liver, difference between liver disease and liver impairment, liver blood tests and how to classify severity of cirrhosis (scarring of the liver).

Further information

British Liver Trust patient information about the liver

NHS conditions article about liver disease

British Liver Trust information about liver blood tests

Cirrhosis

Kieran Reynolds talks to Naz Kanani Alviri, Principal Pharmacist, Hepatology & Liver Transplantation, about liver cirrhosis. Discussion includes what cirrhosis is and how it is diagnosed, the difference between compensated and decompensated cirrhosis, complications of decompensated cirrhosis and initiatives being undertaken to improve the earlier diagnosis of liver disease.

Further information

SPS article about calculating and using the Child-Pugh score

British Association for the Study of the Liver position statement about prescribing weight-adjusted oral paracetamol in adults (available under Resources)

NHS England news article about mobile liver testing scheme

Drugs in liver impairment

Kieran Reynolds talks to Aimee Francisco, Advanced Specialist Gastroenterology Pharmacist and primary care lead at the British Hepatology Pharmacy Group about drugs in liver impairment. Discussion includes key issues to consider when prescribing in liver disease, medicines to avoid (or use with caution) in liver disease, drug induced liver injury and herbal medicines.

Further information

SPS medicines monitoring tool

British Association for the Study of the Liver guidelines for symptom control in adults with advanced liver disease (available under Resources)

British Association for the Study of the Liver position statement about prescribing weight-adjusted oral paracetamol in adults (available under Resources)

LiverTox database

Memorial Sloan Kettering Cancer Center’s About Herbs database

 

Update history

  1. Links updated to improve accessibility
  1. Published

Print this page